Information  X 
Enter a valid email address

Frontera Resources (FRR)

  Print   

Wednesday 19 September, 2018

Frontera Resources

Further re: Update

RNS Number : 1867B
Frontera Resources Corporation
19 September 2018
 

19 September 2018

Frontera Resources Corporation

("Frontera" or "the Company")

Further re: Update

In response to market inquiries with respect to the Company's announcement of 17 September 2018 (the "Announcement"), the Company would like to clarify that it has come to the Company's attention that on 28, 29, 30 August 2018 and 3 September 2018, YA II PN, Ltd. arbitrarily sold 82,077,412 ordinary shares in the Company that have not been authorised, issued and admitted to trading by the Company.

 

As described in the Announcement, the Company immediately commenced investigation into the facts surrounding these sales to clarify what shares have been sold and why, and its advisers sent the communication to and raised this issue with YA II PN, Ltd. 

 

The Company is continuing to investigate YA II PN Ltd.'s actions in that regard, particularly the above sales and YA II PN, Ltd.'s any other possible unauthorised dealings in shares, and is unable to comment further at this time pending further investigation with its advisers and the receipt of legal advice.

 

The Company will update the market about the foregoing issue in due course.

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

Enquiries:

 

Frontera Resources

001 (713) 585- 3216

 

Zaza Mamulaishvili

 

 

[email protected]

 

 

 

Cairn Financial Advisers LLP

+44 (0) 20 7213 0880

 

Jo Turner / Liam Murray

 

 

 

WH Ireland Limited

+44 (0) 20 3411 1880

 

James Joyce / Alex Bond

 

 

 

Yellow Jersey 

+44 (0) 203 735 8825

 

Tim Thompson

 

 

Harriet Jackson

 

 

Henry Wilkinson

 

 

 

 

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
FUREAFNPFSSPEAF

a d v e r t i s e m e n t